Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Barnes

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Transactions of the St. John'S Hospital Dermatological Society|January 1, 1974
Pruritus and thyrotoxicosisH M Barnes, I Sarkany, C D Calnan
Bioresource Technology|February 3, 2005
Performance of copper naphthenate and its analogs as ground contact wood preservativesH M Barnes, T L Amburgey, M G Sanders
American Journal of Hematology|November 1, 1981
Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosisH M Barnes, J T Prchal, C W Scott
American Journal of Hematology|February 1, 1983
Febrile transfusion reaction following initial transfusion in a man with immunoblastic lymphadenopathy and granulocyte autoantibodiesH M Barnes, M C Poon, S T Huang, et al.
Bioresource Technology|April 10, 2010
Suitability of live and fire-killed small-diameter ponderosa and lodgepole pine trees for manufacturing a new structural wood compositeJ M Linton, H M Barnes, R D Seale, et al.
Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapyR A Beveridge, J A Miller, A N Kales, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Transactions of the St. John'S Hospital Dermatological Society|January 1, 1974
Pruritus and thyrotoxicosisH M Barnes, I Sarkany, C D Calnan
Bioresource Technology|February 3, 2005
Performance of copper naphthenate and its analogs as ground contact wood preservativesH M Barnes, T L Amburgey, M G Sanders
American Journal of Hematology|November 1, 1981
Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosisH M Barnes, J T Prchal, C W Scott
American Journal of Hematology|February 1, 1983
Febrile transfusion reaction following initial transfusion in a man with immunoblastic lymphadenopathy and granulocyte autoantibodiesH M Barnes, M C Poon, S T Huang, et al.
Bioresource Technology|April 10, 2010
Suitability of live and fire-killed small-diameter ponderosa and lodgepole pine trees for manufacturing a new structural wood compositeJ M Linton, H M Barnes, R D Seale, et al.
Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapyR A Beveridge, J A Miller, A N Kales, et al.
Pageof 2